BioHealth News
Waisman Biomanufacturing and RoosterBio Announce Collaboration for GMP Manufacturing of Cell and Exosome Therapies
FREDERICK, Md., Feb. 13, 2024 /PRNewswire-PRWeb/ -- Waisman Biomanufacturing, a leading contract development and manufacturing organization (CDMO) which is strategically part of the University of Wisconsin Madison,…
Read More
Career Opportunity with BHI: Life Sciences Business Strategist
BioHealth Innovation (BHI) is an innovation intermediary that facilitates the commercialization of emerging technologies in the BioHealth Capital Region (Maryland, DC and Virginia). We…
Read More
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a Phase 3 cancer immunotherapy company, today announced the pricing of an offering of 3,875,000…
Read More
CityBiz+ – Biosim AI
Biosim AI, founded by a professor at the University of Maryland in College Park, has closed on $12.25 million in its bid to commercialize technology to “enable…
Read More
Amarex Celebrates Its 25th Anniversary
Germantown, MD, USA (February 07, 2024) – Amarex Clinical Research, LLC, an NSF company, announces December 2023 marked its 25th year advancing patient access…
Read More
I-Mab Signs Agreement to Divest its Assets and Business Operations in China to Become Rockville-Based Biotech
ROCKVILLE, Md., Feb. 7, 2024 /PRNewswire/ -- I-Mab (the "Company") (NASDAQ: IMAB), a global biotech company exclusively focused on bringing highly differentiated immunotherapies and biologics for cancer treatment to…
Read More
BHI Remembers Dr. William G. Hearl: A Pillar of the BioHealth Capital Region
BioHealth Innovation (BHI) deeply mourns the loss of Dr. William G. Hearl, a former BHI Board member and a prominent contributor to the BioHealth…
Read More
BullFrog AI Announces Closing Of $5.7M Public Offering
GAITHERSBURG, Md., Feb. 05, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company…
Read More
NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GAITHERSBURG, Md., Feb. 06, 2024 (GLOBE NEWSWIRE) -- NexImmune, Inc. a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted…
Read More
Children’s National Event: Navigating from Research to Market Approval: The AGAMREE Journey
Join Children’s National Hospital for a pivotal symposium on the journey of AGAMREE® from academic research to market approval for DMD treatment in children.…
Read More
BISNOW: In Nation’s Tightest Life Sciences Market, There Is Little Appetite To Build More Space
February 1, 2024 Emily Wishingrad - The life sciences real estate train, which just a few years ago was reaching top speeds, is now pressing down firmly on the brakes. …
Read More
Baltimore Banner: One biotech company is leaving, one is staying. What does that say about Baltimore?
Meredith Cohn - 2/6/2024 - Thrive Earlier Detection Corp., a startup company based on early cancer testing technology developed at the Johns Hopkins University, was snatched up…
Read More
WBJ: AstraZeneca doubles down on Montgomery County with $300M investment
By Sara Gilgore – Staff Reporter, Washington Business Journal - AstraZeneca PLC (NYSE: AZN) is leaving no doubt about its commitment to Montgomery County, pouring $300 million…
Read More
GEN: Novo Holdings Buys Catalent for $16.5B; Sells Three Sites to Novo Nordisk for $11B
By Alex Philippidis -February 5, 2024 - Novo Holdings, the asset manager of the foundation that controls Novo Nordisk, has agreed to acquire contract development…
Read More
J.P. Morgan Releases 2024 Innovation Economy Outlook: What’s Next for Venture Capital?
J.P. Morgan has released its 2024 Innovation Economy Outlook, offering valuable insights for those interested in the future of venture capital, investment trends, and…
Read More